Sentences with phrase «genomic epidemiology»

The 16th CRG Symposium: Seventh International Workshop on Genomic Epidemiology will take place at the PRBB Auditorium from 20 to 22 September 2017 will gather speakers to discuss about the progress in sequencing and with other technologies for biomolecular analysis, and their applications in...
Topics this year include genomic epidemiology of the host, vector and parasite, highlighting the practical relevance of this research to global health, including anti-malarial drug resistance, insecticide resistance, vaccine design, and mechanisms of protective immunity.
This Meeting was immediatly followed by the Genomic Epidemiology of Malaria Advanced course.
This year's GEM Travel Awards are supporting 12 researchers from 11 countries to participate in the upcoming Genomic Epidemiology of Malaria conference in Hinxton, UK.
• Diseases caused by bacteria • What bacterial genomes look like • Genome sequencing technology • Mechanisms of transmission and resistance • Genomic epidemiology — tracking the spread of bacterial pathogens • Antimicrobial resistance
We are looking forward to attending the upcoming 2012 Wellcome Trust Conference on Genomic Epidemiology of Malaria (GEM), June 10 - 13th at the Welcome Trust Conference Centre on the Genome Campus (home of The Sanger Institute) in Hinxton.
The families were ascertained from multiple sites, including contributors to the Alzheimer Disease Genetics Consortium (ADGC), and the neurology working group of the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium (CHARGE).
Participants in the 6th International Workshop on Genomic Epidemiology are welcomed to present their research results with a short abstract of 400 words.
African scientists have a role to play in tackling malaria and as a network we will be able to further the science of genomic epidemiology in Africa, and help many young researchers to get state - of - the - art technical and analytical training in this challenging field.»
Professor Abdoulayé Djimdé, Director of the PDNA said «The idea for the PDNA began in conversations among members of MalariaGEN at the Genomic Epidemiology of Malaria Conference in Hinxton, UK in 2012.
The meeting explored the genomic epidemiology of the host, vector and parasite, highlighting the practical relevance of this research to global health, including antimalarial drug resistance, insecticide resistance, vaccine design, and mechanisms of protective immunity.

Not exact matches

Medical fields like neurology, bio-chemistry, pharmacology, virology, epidemiology, genomics, oncology, etc. are all dependent on the application of evolutionary principles.
Twenty - first century science is driven, in large part, by challenges at interfaces, including those between the environmental and life sciences — public health, ecology, genomics, cell biology, epidemiology, immunology, neurobiology, physiology, evolutionary biology... and the mathematical sciences.
The environment seemed highly competitive and efforts by young faculty to search for grants to support their research in genomics, ecology, and epidemiology were evident.
«The merging of India's strengths in IT with enormous wealth of world wide public data in genomics, medicine, biology, epidemiology and social sciences might provide a ripe venue for new modes of engagement.»
- CER researchers come from a range of professional disciplines including clinical medicine, epidemiology, bioinformatics, biostatistics, health services research, economics, methods research, decision and cognitive sciences, genomics, proteomics, library science, communications, as well as other areas.
Co-authors with Gopalakrishnan and Wargo are Christine Spencer, Tatiana Karpinets, Ph.D., Robert Jenq, M.D., and Andrew Futreal, Ph.D., of Genomic Medicine; Alexandre Reuben, Ph.D., Peter Prieto, M.D., and Jeffrey Gershenwald, M.D., of Surgical Oncology; Kristi Hoffman, Ph.D., of Cancer Prevention; Michael Tetzlaff, Ph.D., M.D., and Alexander Lazar, M.D., Ph.D., of Pathology; Michael Davies, M.D., Ph.D., and Patrick Hwu, M.D., of Melanoma Medical Oncology; Padmanee Sharma, M.D., Ph.D., of Genitourinary Medical Oncology and Immunology; Jim Allison, Ph.D., of Immunology; Carrie Daniel - MacDougall, Ph.D., of Epidemiology; and Diane Hutchinson, Ph.D., Nadim Ajami, Ph.D., and Joseph Petrosino, Ph.D., of Baylor College of Medicine.
«Metabolomics is now often used to accompany large genomic cohort studies from biobanks, to correlate genotype and genomic variants with specific phenotypes, to complement nutritional studies monitoring food components or endogenous metabolites, or to support measurements in epidemiology studies,» says Andreas Huhmer, director of proteomics and metabolomics marketing at Thermo Fisher Scientific, headquartered in Waltham, Massachusetts.
The MRC Centre for Genomics and Global Health (CGGH) is supporting MalariaGEN by developing web - based applications for sharing and analysing large genomic datasets, and by helping to build research capacity for genetic epidemiology research in malaria - endemic regions.
Researchers in NCI's Division of Cancer Epidemiology and Genetics (DCEG) integrate tissue profiling into studies examining the causes of cancer to better understand the process by which normal cells are transformed into cancer cells (carcinogenesis) and to pinpoint factors associated with risk for developing specific molecular or genomic subtypes.
Topics explored by AJHG include behavioral genetics, biochemical genetics, clinical genetics, cytogenetics, dysmorphology, gene therapy, genetic counseling, genetic epidemiology, genomics, immunogenetics, molecular genetics, neurogenetics, and population genetics.
This diverse community brings together individuals with expertise from several fields including genomics, statistics, epidemiology, software engineering, ethics, programme management and communications.
From the Department of Medicine, Division of Hematology, Brigham and Women's Hospital (S.J., A.J.S., M.M.) and Harvard Medical School (B.L.E.), the Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital (E.S.) and Harvard Medical School (G.K.S., P.L.), the Department of Pathology (S.J.) and the Center for Genomic Medicine (P.N., S.K.), Massachusetts General Hospital, the Department of Medicine, Division of Cardiology, and Cardiovascular Research Center (P.N., S.K.), and the Department of Medicine (A.G.B.), Massachusetts General Hospital and Harvard Medical School, and the Departments of Medical Oncology (C.J.G.) and Biostatistics and Computational Biology (D.N.), Dana - Farber Cancer Institute, Boston, and the Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge (P.N., A.G.B., N.G., S.G., S.K.)- all in Massachusetts; the Department of Cardiology, University Hospital, Parma, Italy (D.A.); the Department of Medicine, Division of Cardiology, Mt. Sinai School of Medicine, New York (U.B., R.M., V.F.); Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid (V.F.); Medical Research Council - British Heart Foundation Cardiovascular Epidemiology Unit and National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, and the British Heart Foundation, Cambridge Centre of Excellence, Department of Medicine, University of Cambridge, Cambridge (J.D.), and the Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton (J.D.)- both in the United Kingdom; the Center for Non-Communicable Diseases, Karachi, Pakistan (P.F., D.S.); the Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia (D.S.); and the Department of Clinical Sciences Malmö, Lund University, Lund, Sweden (O.M.).
The CEER program, established in 2004, is designed to bring together experts in wide - ranging fields - bioethics, law, behavioral and social sciences, epidemiology, public health, public policy, genomics and clinical research - to study the potential societal implications of genomic information and research.
The Area of Genomic Medicine is devised as a scientific production structure which will preferably include research groups centred on work in the area of genetic epidemiology of some of the main public health problems (cancer, autoimmune diseases, cardiovascular diseases, diabetes, rare diseases, etc.).
Despite this, the population genomics and epidemiology of MDR K. pneumoniae at the national level are still poorly understood.
Despite growing evidence of the clinical importance of this species, knowledge about its population epidemiology and genomic architecture is limited.
Signature research includes infectious disease, genomics, comparative medicine, raptor conservation, public health, epidemiology and dairy, swine, and avian medicine.
A special emphasis is given to valve disease, congenital heart disease, and inherited cardiovascular conditions as well as coronary disease, heart failure, arrhythmias, imaging, epidemiology, global health, genomics and translational science.
a b c d e f g h i j k l m n o p q r s t u v w x y z